(Chemical) Bonding is what makes life possible

My research journey, deeply rooted in applying mass spectrometry (MS) in biomedical sciences, has been a testament to the transformative power of interdisciplinary approaches. With a profound interest in pioneering non-invasive monitoring methods for diseases such as bladder cancer and renal cell carcinoma, I have always been driven by the vision of harnessing technology to guide medical decisions. This vision is about replacing empiric therapy and grounding therapeutic interventions in robust, evidence-based principles. To realise this vision, I have dedicated myself to integrating nano-proteomics, supramolecular separation methods, MS, and computational tools. The goal? Early detection of pathologies and the establishment of reliable screening protocols. But the breadth of my research does not stop there. It spans from biomedical research, delving into the functional foods that combat cardiovascular diseases, to the cutting-edge areas of viral detection and antibiotic resistance. Furthermore, my contributions extend to the characterisation of compounds, particularly for developing sensors. This expansive research landscape, which seamlessly integrates the complexities of human health with the precision of chemical characterisation, underscores my commitment to pushing the boundaries of what is possible in both biomedical and chemical research domains.